ArticleHepatology (Baltimore, Md.)2018

Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway.

Yao Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.